Synthesis and study of the electronic properties of pyrazolo[1,5-c]pyrrolo[1,2-a]quinazoline and pyrazolo[1,5-c]pyrido[1,2-a]quinazoline derivatives

[1]  B. Insuasty,et al.  Synthesis and study of fluorescence properties of novel pyrazolo[4′,3′:5,6]pyrido[2,3-d]pyrimidin-5(6H)-one derivatives , 2015 .

[2]  B. Insuasty,et al.  Annelation of pyrrolo[1,2-a]pyrimidine and pyrido[1,2-a]pyrimidine systems to a pyrazolopyridine framework by a cascade of two cyclization reactions , 2015 .

[3]  Shi-jian Su,et al.  Nitrogen heterocycle-containing materials for highly efficient phosphorescent OLEDs with low operating voltage , 2014 .

[4]  A. Saeed,et al.  Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: synthetic approaches and multifarious applications. , 2014, European journal of medicinal chemistry.

[5]  S. Shyue,et al.  Essential role of transient receptor potential vanilloid type 1 in evodiamine‐mediated protection against atherosclerosis , 2013, Acta physiologica.

[6]  Qiang Z Yu,et al.  Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells. , 2013, Cancer letters.

[7]  V. Andrisano,et al.  A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion Diseases. , 2013, ACS medicinal chemistry letters.

[8]  H. Fujito,et al.  Synthesis, solid-state fluorescence properties, and computational analysis of novel 2-aminobenzo[4,5]thieno[3,2-d]pyrimidine 5,5-dioxides , 2012, Beilstein journal of organic chemistry.

[9]  M. Noolvi,et al.  Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent. , 2011, European journal of medicinal chemistry.

[10]  M. Al-Omar,et al.  Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study. , 2010, European journal of medicinal chemistry.

[11]  Changping Hu,et al.  Pharmacological Effects of Rutaecarpine as a Cardiovascular Protective Agent , 2010, Molecules.

[12]  Y. Ho,et al.  Mono and bis-6-arylbenzimidazo[1,2-c]quinazolines: a new class of antimicrobial agents. , 2009, European journal of medicinal chemistry.

[13]  M. Jachak,et al.  New one‐step synthesis of pyrazolo[1,5‐a]pyrimidine and pyrazolo[1,5‐a]quinazoline derivatives via multicomponent reactions , 2009 .

[14]  Ján Labuda,et al.  Disposable DNA biosensor with the carbon nanotubes–polyethyleneimine interface at a screen-printed carbon electrode for tests of DNA layer damage by quinazolines , 2009, Analytical and bioanalytical chemistry.

[15]  Mark B. Anderson,et al.  Discovery of N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a potent apoptosis inducer and efficacious anticancer agent with high blood brain barrier penetration. , 2009, Journal of medicinal chemistry.

[16]  Jianwei Xu,et al.  Thermally Stable Blue-Light-Emitting Hybrid Organic-Inorganic Polymers Derived from Cyclotriphosphazene , 2008 .

[17]  F. Aslan,et al.  The Synthesis, Characterization and Photophysical Properties of Some New Cyclotriphosphazene Derivatives Bearing Schiff Base , 2008 .

[18]  Craig W Lindsley,et al.  Application of combinatorial chemistry science on modern drug discovery. , 2008, Journal of combinatorial chemistry.

[19]  Suning Wang,et al.  Interaction of 2-(2'-pyridyl)benzimidazolyl derivative ligands with group 12 metal ions: coordination, structures and luminescence. , 2006, Dalton transactions.

[20]  A. Fedorov,et al.  A new family of luminescent compounds: platinum(II) imidoylamidinates exhibiting pH-dependent room temperature luminescence. , 2006, Dalton transactions.

[21]  Stuart C. Wilson,et al.  Targeting the alpha-folate receptor with cyclopenta[g]quinazoline-based inhibitors of thymidylate synthase. , 2006, Bioorganic & medicinal chemistry.

[22]  Matthew H Todd,et al.  Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists. , 2006, Journal of medicinal chemistry.

[23]  L. Gerena,et al.  Antimalarial Activities of New Pyrrolo[3,2-f]Quinazoline-1,3-Diamine Derivatives , 2005, Antimicrobial Agents and Chemotherapy.

[24]  Arabinda Mallick,et al.  Photophysical studies on multichromophoric cyclotriphosphazenes. Trinuclear excimer formation in hexakis(2-naphthyloxy)cyclotriphosphazene , 2005 .

[25]  M. Albrecht,et al.  Anthryl-substituted heterocycles as acid-sensitive fluorescence probes. , 2005, The Journal of organic chemistry.

[26]  M. P. Mahajan,et al.  Synthesis and Biological Activity of Novel Antibacterial Quinazolines (III). , 2005 .

[27]  J. Chern,et al.  Nucleosides XI. Synthesis and antiviral evaluation of 5'-alkylthio-5'-deoxy quinazolinone nucleoside derivatives as S-adenosyl-L-homocysteine analogs. , 2004, Chemical & pharmaceutical bulletin.

[28]  M. Marschall,et al.  Novel Chemical Class of pUL97 Protein Kinase-Specific Inhibitors with Strong Anticytomegaloviral Activity , 2004, Antimicrobial Agents and Chemotherapy.

[29]  Vipan Kumar,et al.  Synthesis and biological activity of novel antibacterial quinazolines. , 2004, Bioorganic & medicinal chemistry letters.

[30]  Lie-Chwen Lin,et al.  Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP , 2004, International journal of cancer.

[31]  S. Schreiber,et al.  A planning strategy for diversity-oriented synthesis. , 2004, Angewandte Chemie.

[32]  D. Lewis,et al.  Effect of structural modification on the inhibitory selectivity of rutaecarpine derivatives on human CYP1A1, CYP1A2, and CYP1B1. , 2003, Bioorganic & medicinal chemistry letters.

[33]  Douglas A. Horton,et al.  The combinatorial synthesis of bicyclic privileged structures or privileged substructures. , 2003, Chemical reviews.

[34]  Jingui Qin,et al.  Polyphophazene containing indole-based dual chromophores: Synthesis and nonlinear optical characterization , 2002 .

[35]  J. Hynes,et al.  Synthesis of 5-substituted quinazolines as potential antimalarial agents. , 1973, Journal of medicinal chemistry.

[36]  Michael Kasha,et al.  Energy Transfer Mechanisms and the Molecular Exciton Model for Molecular Aggregates1, 2 , 1963 .

[37]  P. M. Reddy,et al.  Synthesis and antimicrobial activities of a new class of 6-arylbenzimidazo[1,2-c]quinazolines , 2010 .

[38]  S. Batra,et al.  Search for new pharmacophores for antimalarial activity. Part II: synthesis and antimalarial activity of new 6-ureido-4-anilinoquinazolines. , 2009, Bioorganic & medicinal chemistry.

[39]  Jingui Qin,et al.  A New Postfunctional Approach To Prepare Second-Order Nonlinear Optical Polyphophazenes Containing Sulfonyl-Based Chromophore , 2004 .

[40]  A. R. Williams,et al.  Relative fluorescence quantum yields using a computer-controlled luminescence spectrometer , 1983 .

[41]  M. Kasha,et al.  The exciton model in molecular spectroscopy , 1965 .